ライフサイエンスコーパス: preimmunization

1 Preimmunization activity could have been due to prior in

2 red for high frequencies of fetus loss after preimmunization against paternal tissue Ags.

3 tumor emergence setting, however, for which preimmunization against tumor Ags is sufficient for comp

4 Patients were evaluated preimmunization and 12 weeks postimmunization for diseas

5 Preimmunization and postimmunization sera underwent stra

6 The effects of preimmunization and tolerization with these epitopes on

7 nt intravesical instillations with KLH after preimmunization, and 270 patients were randomly assigned

8 inity contributes to positive selection of a preimmunization B cell repertoire, whereas high-affinity

9 specific CTLs were detected in post- but not preimmunization blood.

10 es on the tumor cells after transfection and preimmunization by full-thickness skin grafts was requir

11 perglycemic (> 200 mg/dl) after intrahepatic preimmunization by injection of 200 low-temperature cult

12 ostimmunization CD4(+) T cells compared with preimmunization CD4(+) T cells.

13 Likewise, the PPS-specific B cells obtained preimmunization consisted primarily of naive, CD27(-) B

14 Significantly, preimmunization does not eliminate systemic vector-induc

15 cages, and stereotypy was rated to determine preimmunization drug response (baseline).

16 Rats receiving peripheral preimmunization followed by Ag into caudate nucleus have

17 The preimmunization geometric mean (GM) Type 5 antibody leve

18 ed rapidly from 0.025% before challenge to a preimmunization level of 0.0003% of CD4(+) T cells.

19 SFC/10(6) PBMC; p = 0.010), as compared with preimmunization levels, were observed.

20 by postimmunization PBMC when compared with preimmunization levels.

21 found to increase bactericidal activity over preimmunization levels.

22 used in repeated vaccination, we report that preimmunization of animals with Ad infected DCs prior to

23 Further studies revealed that preimmunization of BUB mice with V beta 10 peptide alone

24 Preimmunization of C57BL/6 mice with one of the two type

25 Moreover, preimmunization of mice by systemic exposure to adenovec

26 Preimmunization of mice with a panel of selected vaccine

27 Preimmunization of mice with this peptide substantially

28 Preimmunization of susceptible mice with VPI and VP2 fus

29 s was to investigate the effects of vimentin preimmunization on allogeneic and isografted hearts in a

30 reased from 6.6 per 1000 patient-days in the preimmunization period to 14.0 per 1000 patient-days in

31 reased from 5.4 per 1000 patient-days in the preimmunization period to 19.3 per 1000 patient-days in

32 ization CD4(+) T cells compared with that in preimmunization peripheral blood mononuclear cells.

33 lants was not significantly improved by this preimmunization protocol at either transplantation site.

34 ted growth compared with tumors treated with preimmunization rabbit antisera.

35 ained normoglycemia for > 100 days after the preimmunization regimen.

36 Preimmunization resulted in high levels of circulating N

37 Dilutions of preimmunization sera given i.p. 2 h before the bacterial

38 A production and in the return of IgM XNA to preimmunization serum levels, 3 to 7 days after xenotran

39 st to just 5 to 10% inhibition obtained with preimmunization serum.

40 The samples were chosen based on low preimmunization titers and strong postimmunization respo

41 lantation, and it has been hypothesized that preimmunization to antigens on transfused blood may prim

42 e GM lgM level, in contrast, declined to the preimmunization value.

43 Q); in contrast, 36%-63% of the subjects had preimmunization values of antibodies to FHA, PRN, or FIM

44 Of the subjects, 16%-19% had preimmunization values of antibodies to PT that were abo

45 d across a full MHC mismatch by intrahepatic preimmunization with a small number of cultured donor is

46 f autoimmune response to PLP 139-151 because preimmunization with A144 to expand the L141/G142-reacti

47 After preimmunization with Ag-alphaCD180 and boosting with sol

48 Preimmunization with CM but not control ovalbumin abroga

49 did not cross-react with donor antigens and preimmunization with CM had no impact on the survival or

50 he observation that the protective effect of preimmunization with KLH was overcome by rm-IL-12, which

51 Furthermore, preimmunization with L144/R147 protected mice from EAE i

52 PIA) and those protected from the disease by preimmunization with mycobacterial 65-kDa heat shock pro

53 Intriguingly, preimmunization with rAAV8-hAAT vector or with serum of

54 ne transfer of factor IX was not impacted by preimmunization with the other AAV serotypes.

55 otected against live TS/A tumor challenge by preimmunization with TS/A admixed with C. parvum.

56 Mice free of clinical symptoms following preimmunizations with fusion proteins displayed high lev

57 To investigate if preimmunization would increase the level of protection a